Finding the best time to start buprenorphine treatment in jails
Assessing Optimal XR-Buprenorphine Initiation Points in Jail
['FUNDING_R01'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-10880708
This study is looking at the best way to start treatment with buprenorphine for people with opioid use disorder while they are in jail, comparing whether it's better to begin the medication when they first arrive or just before they leave, to help them stay in treatment and avoid relapse after they get out.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10880708 on ClinicalTrials.gov |
What this research studies
This research investigates how to effectively initiate buprenorphine treatment for individuals with opioid use disorder (OUD) while they are incarcerated. It focuses on the timing of treatment initiation, comparing starting the medication at admission versus just before release from jail. By utilizing extended-release buprenorphine injections, the study aims to improve retention in treatment and reduce the risk of relapse and overdose after release. The research will involve monitoring participants' outcomes related to opioid use and overall health during and after their time in jail.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are incarcerated and have a diagnosis of opioid use disorder.
Not a fit: Patients who are not currently incarcerated or do not have opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for individuals with opioid use disorder, ultimately reducing relapse rates and overdose deaths.
How similar studies have performed: Previous studies have shown promising results with extended-release buprenorphine in community settings, indicating potential for success in jail-based interventions.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FARABEE, DAVID J — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: FARABEE, DAVID J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.